Protease nexin-1, tPA, and PAI-1 are upregulated in cryoglobulinemic membranoproliferative glomerulonephritis

Journal of the American Society of Nephrology

Volumn 19, Issue 2, 2008, Pages 243-251

  Taneda, Sekiko ^a,c   Hudkins, Kelly L ^a   Mühlfeld, Anja S ^a,d   Kowalewska, Jolanta ^a   Pippin, Jeffrey W ^b   Shankland, Stuart J ^b   Alpers, Charles E ^a,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; FC RECEPTOR IIB; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASE NEXIN I; RNA; THYMIC STROMA DERIVED T CELL GROWTH FACTOR; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CELL CULTURE; CELL INFILTRATION; CONTROLLED STUDY; CRYOGLOBULINEMIA; CYTOKINE RELEASE; DRUG TARGETING; EXTRACELLULAR MATRIX; FEMALE; FIBRINOLYSIS; GENE EXPRESSION; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE CELL; KIDNEY FIBROSIS; MACROPHAGE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM CELL; MICROARRAY ANALYSIS; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 39049140871     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007030367     Document Type: Article

References (37)

1. Huang Y, Noble N: An unexpected role of plasminogen activator inhibitor-type 1 (PAI-1) in renal fibrosis. Kidney Int 67: 2502-2503, 2005
2. Fogo AB: Renal fibrosis: Not just PAI-1 in the sky. J Clin Invest 112: 326-328, 2003
3. Eddy AA: Plasminogen activator inhibitor-1 and the kidney. Am J Physiol Renal Physiol 283: F209-F220, 2002
4. Feng L, Tang WW, Loskutoff DJ, Wilson CB: Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. J Am Soc Nephrol 3: 1753-1764, 1993
5. Malliaros J, Holdsworth SR, Wojta J, Erlich J, Tipping PG: Glomerular fibrinolytic activity in anti-GBM glomerulonephritis in rabbits. Kidney Int 44: 557-564, 1993
6. Matsuo S, Lopez-Guisa JM, Cai X, Okamura DM, Alpers CE, Bumgarner RE, Peters MA, Zhang G, Eddy AA: Multifunctionality of PAI-1 in fibrogenesis: Evidence from obstructive nephropathy in PAI-1-overexpressing mice. Kidney Int 67: 2221-2238, 2005
7. Oda T, Jung YO, Kim HS, Cai X, Lopez-Guisa JM, Ikeda Y, Eddy AA: PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 60: 587-596, 2001
8. Ingelfinger JR: Forestalling fibrosis. N Engl J Med 349: 2265-2266, 2003
9. Eddy AA, Fogo AB: Plasminogen activator inhibitor-1 in chronic kidney disease: Evidence and mechanisms of action. J Am Soc Nephrol 17: 2999-3012, 2006
10. Angles-Cano E, Rondeau E, Delarue F, Hagege J, Sultan Y, Sraer JD: Identification and cellular localization of plasminogen activators from human glomeruli. Thromb Haemost 54: 688-692, 1985
11. Ferroni P, Guadagni F: Protease nexin-1: A regulator of vascular disease? J Thromb Haemost 4: 320-321, 2006
12. Richard B, Pichon S, Arocas V, Venisse L, Berrou E, Bryckaert M, Jandrot-Perrus M, Bouton MC: The serpin protease nexin-1 regulates vascular smooth muscle cell adhesion, spreading, migration and response to thrombin. J Thromb Haemost 4: 322-328, 2006
13. Scott RW, Bergman BL, Bajpai A, Hersh RT, Rodriguez H, Jones BN, Barreda C, Watts S, Baker JB: Protease nexin: Properties and a modified purification procedure. J Biol Chem 260: 7029-7034, 1985
14. Baker JB, Low DA, Simmer RL, Cunningham DD: Protease-nexin: A cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 21: 37-45, 1980
15. Moll S, Schaeren-Wiemers N, Wohlwend A, Pastore Y, Fulpius T, Monard D, Sappino AP, Schifferli JA, Vassalli JD, Izui S: Protease nexin 1 in the murine kidney: Glomerular localization and up-regulation in glomerulopathies. Kidney Int 50: 1936-1945, 1996
16. Kanse SM, Chavakis T, Al-Fakhri N, Hersemeyer K, Monard D, Preissner KT: Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1. J Cell Sci 117: 477-485, 2004
17. Wakida N, Kitamura K, Tuyen DG, Maekawa A, Miyoshi T, Adachi M, Shiraishi N, Ko T, Ha V, Nonoguchi H, Tomita K: Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-beta1 and aldosterone. Kidney Int 70: 1432-1438, 2006
18. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87: 847-858, 1991
19. Moll S, Menoud PA, Fulpius T, Pastore Y, Takahashi S, Fossati L, Vassalli JD, Sappino AP, Schifferli JA, Izui S: Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritis. Kidney Int 48: 1459-1468, 1995
20. Tang WW, Feng L, Loskutoff DJ, Wilson CB: Glomerular extracellular matrix accumulation in experimental anti-GBM Ab glomerulonephritis. Nephron 84: 40-48, 2000
21. Hamano K, Iwano M, Akai Y, Sato H, Kubo A, Nishitani Y, Uyama H, Yoshida Y, Miyazaki M, Shiiki H, Kohno S, Dohi K: Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis. Am J Kidney Dis 39: 695-705, 2002
22. Krag S, Osterby R, Chai Q, Nielsen CB, Hermans C, Wogensen L: TGF-beta1-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man. Lab Invest 80: 1855-1868, 2000
23. Gaedeke J, Noble NA, Border WA: Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells. Kidney Int 66: 112-120, 2004
24. Taneda S, Hudkins KL, Cui Y, Farr AG, Alpers CE, Segerer S: Growth factor expression in a murine model of cryoglobulinemia. Kidney Int 63: 576-590, 2003
25. Muhlfeld AS, Segerer S, Hudkins K, Carling MD, Wen M, Farr AG, Ravetch JV, Alpers CE: Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis. Am J Pathol 163: 1127-1136, 2003
26. Taneda S, Segerer S, Hudkins KL, Cui Y, Wen M, Segerer M, Wener MH, Khairallah CG, Farr AG, Alpers CE: Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 159: 2355-2369, 2001
27. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M: Minimum information about a microarray experiment (MIAME): Toward standards for microarray data. Nat Genet 29: 365-371, 2001
28. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of muscle-specific actin in glomerulonephritis. Kidney Int 41: 1134-1142, 1992
29. Rosenberg I, Cherayil BJ, Isselbacher KJ, Pillai S: Mac-2-binding glycoproteins: Putative ligands for a cytosolic beta-galactoside lectin. J Biol Chem 266: 18731-18736, 1991
30. Alpers CE, Davis CL, Barr D, Marsh CL, Hudkins KL: Identification of platelet-derived growth factor A and B chains in human renal vascular rejection. Am J Pathol 148: 439-451, 1996
31. Alpers CE, Hudkins KL, Ferguson M, Johnson RJ, Rutledge JC: Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor. Kidney Int 48: 146-154, 1995
32. Hudkins KL, Le QC, Segerer S, Johnson RJ, Davis CL, Giachelli CM, Alpers CE: Osteopontin expression in human cyclosporine toxicity. Kidney Int 60: 635-640, 2001
33. Wolf G, Schroeder R, Thaiss F, Ziyadeh FN, Helmchen U, Stahl RA: Glomerular expression of p27Kip1 in diabetic db/db mouse: role of hyperglycemia. Kidney Int 53: 869-879, 1998
34. Taneda S, Hudkins KL, Topouzis S, Gilbertson DG, Ophascharoensuk V, Truong L, Johnson RJ, Alpers CE: Obstructive uropathy in mice and humans: Potential role for PDGF-D in the progression of tubulointerstitial injury. J Am Soc Nephrol 14: 2544-2555, 2003
35. Kikuchi S, Pastore Y, Fossati-Jimack L, Kuroki A, Yoshida H, Fulpius T, Araki K, Takahashi S, Lemoine R, Reininger L, Izui S: A transgenic mouse model of autoimmune glomerulonephritis and necrotizing arteritis associated with cryoglobulinemia. J Immunol 169: 4644-4650, 2002
36. Banas MC, Parks WT, Hudkins KL, Banas B, Holdren M, Iyoda M, Wietecha TA, Kowalewska J, Liu G, Alpers CE: Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney. J Histochem Cytochem 55: 275-285, 2007
37. Pelton RW, Hogan BL, Miller DA, Moses HL: Differential expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine palate formation. Dev Biol 141: 456-460, 1990